RE:RE:RE:phm valuationUsing the same source... phm has a -22% margin
https://www.theglobeandmail.com/globe-investor/markets/stocks/summary/?q=PHM-X
I'm guessing the information on globe investor is outdated...
However, if you go to cxr's webcast on the covis asset acquisition update; Thompson states the margins are in the 90% range...
And, if you want to apply a specialty pharma business multiple to a healthcare service business, go ahead. I just don't think others are. With that in mind, something that PHM has in common with CXR, is that they do sell coumadin to its clients, which is where their large organic growth is mostly derived from considering that that product has 80% margins.
Cheers